Patent Assignment
Reel/Frame 064087/0951
Assignment of Assignor's Interest
Recorded: 2023-06-27
Pages: 3
Assignor
WHITING, SAM H.
Executed: 2023-06-20
Assignee
TEMPEST THERAPEUTICS, INC.
2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CALIFORNIA, 94005
Covered Property
(1)
Uses of EP2/EP4 Antagonist Compounds for Treating Familial Adenomatous Polyposis (Fap)
Application:
63/383,132 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Dec 28, 2022
From: TEMPESTTX, INC. (F/K/A TEMPEST THERAPEUTICS, INC.); TEMPEST THERAPEUTICS, INC. (F/K/A MILLENDO THERAPEUTICS, INC.); MILLENDO THERAPEUTICS US, INC.
To: OXFORD FINANCE LLC
Reel/Frame 062221/0808 →
Assignment of Assignor's Interest
Jun 27, 2023
From: FRANCICA, BRIAN
To: TEMPEST THERAPEUTICS, INC.
Reel/Frame 064087/0897 →
Release of Security Interest
Apr 10, 2025
From: OXFORD FINANCE LLC
To: TEMPESTTX, INC.; TEMPEST THERAPEUTICS, INC.; MILLENDO THERAPEUTICS US, INC.
Reel/Frame 070806/0566 →